28172-17-0

Basic information

• Product Name: tetrahydrocannabivarin 9
• Synonyms: tetrahydrocannabivarin 9
• CAS NO: 28172-17-0
• Molecular Formula: C19H26O2
• Molecular Weight: 286.40854
• Mol File: 28172-17-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 360.6°Cat760mmHg
• Flash Point: 137.6°C
• Appearance: /
• Density: 1.034g/cm³
• Vapor Pressure: 1.06E-05mmHg at 25°C
• Refractive Index: 1.535
• CAS DataBase Reference: tetrahydrocannabivarin 9(CAS DataBase Reference)
• NIST Chemistry Reference: tetrahydrocannabivarin 9(28172-17-0)
• EPA Substance Registry System: tetrahydrocannabivarin 9(28172-17-0)

Safety Data

• Hazardous Substances Data: 28172-17-0(Hazardous Substances Data)

Usage

General Description

Tetrahydrocannabivarin 9 (THCV) is a compound found in cannabis that resembles tetrahydrocannabinol (THC) in molecular structure, but has different effects. Unlike THC, which has a psychoactive effect, THCV might actually mitigate some of the intense psychoactive effects of THC, like anxiety and paranoia. Research shows possible benefits of THCV for diabetes and obesity due to its appetite-suppressing quality, while also indicating benefits for Alzheimer's and Parkinson's through neuroprotective properties. However, it is found in much smaller quantities in cannabis plants, making it less commonly consumed or studied. Further research is needed to fully understand its therapeutic potential.

InChI:InChI=1/C19H26O2/c1-5-6-13-10-16(20)18-14-9-12(2)7-8-15(14)19(3,4)21-17(18)11-13/h9-11,14-15,20H,5-8H2,1-4H3

Upstream product

• 64898-06-2 (6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromene-2-carboxylic acid methyl ester 
• 1179328-06-3 Δ9-tetrahydrocannabivarin tosylate 
• 500-49-2 5-propyl-1,3-benzenediol 
• 20053-40-1 cis-Δ²-p-menthene-1,8-diol 
• 41395-10-2 1,3-dimethoxy-5-propylbenzene 
• 41497-31-8 3,5-dimethoxyphenyl ethyl ketone 
• 155586-39-3 (3,5-dimethoxyphenyl)-N-methoxy-N-methylcarboxamide 
• 1132-21-4 3,5-dimethoxybenzoic acid 
• 17213-57-9 3,5-dimethoxybenzoyl chloride 
• 24274-48-4 cannabidivarin 
• 1354050-38-6 4-bromo-2,6-dimethoxy-benzaldehyde 
• 917-64-6 methyl magnesium iodide 
• 861892-40-2 (4R)-1-methyl-4-(2-(1-propylene))-2-cyclohexene-2-ol 

Downstream Products

• 96912-65-1 Δ⁹-tetrahydrocannabivarin-11-oic acid 
• 33745-21-0 cannabivarin 

Relevant articles and documents

CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME

The present disclosure relates to new cannabinoid derivatives and precursors and catalytic asymmetric processes for their preparation. The disclosure also relates to pharmaceutical compositions and pharmaceutical and analytical uses of the new cannabinoid derivatives. For instance, the disclosure relates to the preparation of new precursors, and the use of such precursor compounds for the preparation of isotope labelled cannabinoid products using chiral and achiral catalysts and catalytic processes. The deuterium, carbon-13 and carbon-14 containing compounds can be prepared and purified prior to transformation to the desired individual deuterated cannabinoid products.

SYNTHESIS OF PHYTOCANNABINOIDS INCLUDING A DECARBOXYLATION STEP

method for decarboxylating a carboxylated phytocannabinoid compound of Formula I to form a phytocannabinoid compound of Formula II: Formula I Formula II wherein: R1 is selected from the group consisting of: substituted or unsubstituted C1-C5 alkyl; R2 is selected from the group consisting of: OH or O, and R3 is selected from the group consisting of: a substituted or unsubstituted cyclohexene, a substituted or unsubstituted C2-C8 alkene, or a substituted or unsubstituted C2-C8 dialkene; or R2 is O, and R2 and R3 together form a ring structure in which R2 is an internal ring atom; wherein the method includes heating a reaction mixture comprising the carboxylated phytocannabinoid compound and a polar aprotic solvent in the presence of a LiCl for a time sufficient to decarboxylate at least a portion of the carboxylated phytocannabinoid compounds and form the phytocannabinoid compound.

METHOD FOR PURIFYING CANNABINOID COMPOUNDS

The present invention relates to methods for purifying one or two cannabinoid compounds using simulated moving bed chromatography, wherein the cannabinoid compound(s) is/are obtained in the extract and/or the raffinate with the total amount of isomeric impurities being below detection level. In particular, the present invention relates to methods for the purification of cannabidiol, trans-(-)-delta-9-tetrahydrocannabinol, cannabidivarin, trans-(-)-delta-9-tetrahydrocannabivarin and cannabigerol which have been obtained by enantiopure synthesis.